share_log

Connect Biopharma | SC 13D: Statement of acquisition of beneficial ownership by individuals-Panacea Innovation Limited(16.2%),Panacea Venture Healthcare Fund II, L.P.(16.2%), etc.

康乃德生物 | SC 13D:超過5%持股股東披露文件-Panacea Innovation Limited(16.2%),Panacea Venture Healthcare Fund II, L.P.(16.2%)等

SEC announcement ·  02/13 16:38
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息